Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Familial Hypophosphatemic Rickets”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT07745179
What this trial is testing

Natural History Study: ENPP1 Deficiency or the Early-Onset Form of ABCC6 Deficiency

Who this might be right for
Ectonucleotide Pyrophosphatase/phosphodiesterase1 DeficiencyATP-Binding Cassette Subfamily C Member 6 DeficiencyGeneralized Arterial Calcification of Infancy+2 more
Inozyme Pharma 23
Not applicableStudy completedNCT04184661
What this trial is testing

Burosumab and 1-25 (OH) Vitamin D on Human Osteoclasts

Who this might be right for
Hypophosphatemic Rickets
Hospices Civils de Lyon 52
Testing effectiveness (Phase 2)Study completedNCT02750618
What this trial is testing

Study of the Safety, Pharmacodynamics (PD) and Efficacy of KRN23 in Children From 1 to 4 Years Old With X-linked Hypophosphatemia (XLH)

Who this might be right for
X-Linked Hypophosphatemia
Kyowa Kirin, Inc. 13
Large-scale testing (Phase 3)Study completedNCT04308096
What this trial is testing

KRN23 in Adult and Pediatric Patients With X-linked Hypophosphatemic Rickets/Osteomalacia

Who this might be right for
XLH
Kyowa Kirin Co., Ltd. 27
Not applicableLooking for participantsNCT07183579
What this trial is testing

Effective Dosing of Burosumab in XLH

Who this might be right for
X-linked Hypophosphatemia (XLH)
University of Nottingham 120
Testing effectiveness (Phase 2)WithdrawnNCT06739980
What this trial is testing

The ENABLE Study: Safety and Efficacy Study of INZ-701 in Patients With ENPP1 Deficiency

Who this might be right for
Ectonucleotide Pyrophosphatase/phosphodiesterase1 DeficiencyAutosomal Recessive Hypophosphatemic RicketsGeneralized Arterial Calcification of Infancy 1
Inozyme Pharma
Large-scale testing (Phase 3)UnknownNCT04872907
What this trial is testing

Prevention of Spontaneous Dental Abscesses in Children With X-linked Hypophosphatemia : a RCT

Who this might be right for
X-linked Hypophosphatemia (XLH)
Assistance Publique - Hôpitaux de Paris 60
Not applicableUnknownNCT05312086
What this trial is testing

Muscle Abnormalities in Children With XLH

Who this might be right for
Muscle WeaknessXLH
Assistance Publique - Hôpitaux de Paris 30
Early research (Phase 1)Study completedNCT00195936
What this trial is testing

Effect of Cinacalcet on Parathyroid Hormone Secretion in Children and Adolescents With Hypophosphatemic Rickets

Who this might be right for
Hypophosphatemic Rickets, X-Linked Dominant
Children's Mercy Hospital Kansas City 8
Not applicableUnknownNCT06248632
What this trial is testing

Effect of Burosumab on the Inflammatory Profile of Patients With X-linked Hypophosphatemic Rickets FLAM-XLH

Who this might be right for
X-Linked Hypophosphatemic Rickets
Hospices Civils de Lyon 20
Not applicableStudy completedNCT05181839
What this trial is testing

Describe the Lived Experience of XLH for Adolescents at End of Skeletal Growth

Who this might be right for
X-Linked Hypophosphatemia
Kyowa Kirin Pharmaceutical Development Ltd 25
Not applicableStudy completedNCT04049877
What this trial is testing

Retrospective and Prospective Disease Progression and Quality of Life in XLH

Who this might be right for
X-linked Hypophosphatemia (XLH)
Medialis Ltd. 11
Not applicableLooking for participantsNCT06065852
What this trial is testing

National Registry of Rare Kidney Diseases

Who this might be right for
Adenine Phosphoribosyltransferase DeficiencyAH AmyloidosisAHL Amyloidosis+81 more
UK Kidney Association 35,000
Not applicableStudy completedNCT05687474
What this trial is testing

Baby Detect : Genomic Newborn Screening

Who this might be right for
Congenital Adrenal HyperplasiaFamilial Hyperinsulinemic Hypoglycemia 1Phosphoglucomutase 1 Deficiency+121 more
Centre Hospitalier Universitaire de Liege 6,824
Post-approval studies (Phase 4)Study completedNCT04842019
What this trial is testing

Study to Assess the Safety, Pharmacokinetics and Efficacy of KRN23 in Adult Chinese Patients With XLH

Who this might be right for
X-linked Hypophosphatemia (XLH)
Kyowa Kirin Co., Ltd. 18
Testing effectiveness (Phase 2)Study completedNCT02163577
What this trial is testing

Study of KRN23 (Burosumab), a Recombinant Fully Human Monoclonal Antibody Against Fibroblast Growth Factor 23 (FGF23), in Pediatric Subjects With X-linked Hypophosphatemia (XLH)

Who this might be right for
X-linked Hypophosphatemia
Kyowa Kirin, Inc. 52
Large-scale testing (Phase 3)Study completedNCT03581591
What this trial is testing

Open Label Trial Assessing Safety and Efficacy of Burosumab (KRN23), in a Patient With ENS and Hypophosphatemic Rickets

Who this might be right for
HypophosphatemiaHypophosphatemic RicketsPain, Chronic
Redwood Dermatology Sciences 1
Post-approval studies (Phase 4)Study completedNCT04146935
What this trial is testing

Examining the Effect of Burosumab on Muscle Function

Who this might be right for
X-linked Hypophosphatemia
Yale University 10
Early research (Phase 1)Ended earlyNCT01748812
What this trial is testing

Cinacalcet for Fibroblast Growth Factor 23 (FGF23)-Mediated Hypophosphatemia (Hypophosphatemic Rickets)

Who this might be right for
Osteomalacia
National Institute of Dental and Craniofacial Research (NIDCR) 1
Post-approval studies (Phase 4)UnknownNCT04419363
What this trial is testing

Burosumab in Children and Adolescents With X-linked Hypophosphatemia

Who this might be right for
Rare DiseasesX-linked Hypophosphatemia
Bicetre Hospital 57
Next Page